מטוג'קט 50 מ"ג / מ"ל

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

METHOTREXATE 50 MG/ML

Dostupno od:

TZAMAL BIO-PHARMA LTD

ATC koda:

L01BA01

Farmaceutski oblik:

SOLUTION FOR INJECTION

Administracija rute:

S.C, I.M, I.V

Proizveden od:

MEDAC GESELLSCHAFT FUER KLIN.SPEZIAL.mbh

Terapijska grupa:

METHOTREXATE

Terapijske indikacije:

Psoriasis:because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequate

Datum autorizacije:

2011-02-01